Dec 5, 2025 • 5 min read

Pestilence & Profit: Is RFK Jr.'s Vaccine War Actually Bullish for Biotech?

RFK Jr. slashes mRNA funding while the CDC delays Hepatitis B vaccines. A cynical look at how disease outbreaks could fuel a volatile new era for biotech stocks.

#Biotech#RFK Jr#Stocks